Baxter International | هزینه بهره بدهی



Interest Expense On Debt تغییر دادن تاریخ
Abbott USD 45M 6M 2024-12
AtriCure USD 1.45M 59K 2024-12
Avanos Medical USD 2.8M 400K 2024-12
Baxter International USD 100M 1000K 2024-12
Becton, Dickinson and Co. USD 155M 0 2024-12
Boston Scientific USD 80M 1000K 2024-12
Cooper Companies USD 26M 1000K 2025-01
Dexcom USD 4.9M 200K 2024-12
Edwards Lifesciences 15.5M 1000K 2024-06
Fresenius 116M 105.2M 2024-09
Globus Medical 775K 1.56M 2024-09
Halozyme Therapeutics USD 4.54M 16K 2024-12
ICU Medical USD 23.46M 3.83M 2024-12
Insulet USD -1600000 6.8M 2024-12
Integra LifeSciences USD 18.98M 389K 2024-12
J&J USD 137M 56M 2024-12
Laboratory Of America USD 63.4M 13M 2024-12
Masimo USD 10M 500K 2024-12
Medtronic USD 179M 30M 2025-01
Merit Medical Systems USD 7.99M 492K 2024-12
Quest Diagnostics USD 65M 16M 2024-12
Smith & Nephew 70M 0 2024-06
Stryker 42M 11M 2024-09
Tandem Diabetes Care USD 1.86M 5K 2024-12
Teleflex USD 18.63M 2.42M 2024-12
Terumo 3.63B 3.57B 2024-09
Zimmer Biomet Holdings USD 61.9M 7.6M 2024-12



Baxter International هزینه بهره بدهی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2025.